Archive - Latest News Search Engine - Global and Local Breaking News

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

8th Annual Plunge for Elodie Poised to Surpass $3 Million Raised for EB Research Partnership

8th Annual Plunge for Elodie Poised to Surpass $3 Million Raised for EB Research Partnership

MedComms Experts Announces Strategic Investment by The Brydon Group

MedComms Experts Announces Strategic Investment by The Brydon Group

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery

Your briefing

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

TORONTO, Feb. 28, 2025 /PRNewswire/ -- In the context of the global economy's digital transformation, Artificial Intelligence (AI) has emerged as a pi...

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

8th Annual Plunge for Elodie Poised to Surpass $3 Million Raised for EB Research Partnership

Small hometown fundraiser turned global movement for rare disease to be held across 21+ locations worldwide WELLESLEY, Mass., Feb. 28, 2025 /PRNewswir...

8th Annual Plunge for Elodie Poised to Surpass $3 Million Raised for EB Research Partnership

MedComms Experts Announces Strategic Investment by The Brydon Group

NEW YORK, Feb. 28, 2025 /PRNewswire/ -- MedComms Experts ("MCE" or the "Company"), a global provider of rare-disease-focused medical communications se...

MedComms Experts Announces Strategic Investment by The Brydon Group

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS...

The prion program utilizes Apertura's preclinical development data with an AAV capsid targeting human Transferrin Receptor 1 (TfR1) to provide a roadm...

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery